Haverford Trust CO Gilead Sciences, Inc. Transaction History

Haverford Trust CO

$10.2 Billion
Q3 2024

A detailed history of Haverford Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Haverford Trust CO holds 11,615 shares of GILD stock, worth $1.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,615

Previous 11,822 1.75%

Holding current value

$1.04 Million

Previous $811,000 19.98%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$66.59 - $83.99 $13,784 - $17,385	-207 Reduced 1.75%	11,615 $973,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $141,140 - $162,886	-2,235 Reduced 15.9%	11,822 $811,000
Q1 2024 May 02, 2024	BUY	$71.58 - $87.29 $55,259 - $67,387	772 Added 5.81%	14,057 $1.03 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $2,051 - $2,326	-28 Reduced 0.21%	13,285 $1.08 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $106,473 - $116,164	-1,440 Reduced 9.76%	13,313 $997,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $612,260 - $698,368	-8,055 Reduced 35.32%	14,753 $1.14 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $54,735 - $62,360	-708 Reduced 3.01%	22,808 $1.89 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $152,995 - $219,648	-2,455 Reduced 9.45%	23,516 $2.02 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $289,364 - $330,528	-4,860 Reduced 15.76%	25,971 $1.6 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $30,245 - $34,065	-524 Reduced 1.67%	30,831 $1.91 Million
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $8.15 Million - $10.2 Million	-140,660 Reduced 81.77%	31,355 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $169,726 - $192,642	2,616 Added 1.54%	172,015 $12.5 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $836,106 - $902,066	12,352 Added 7.87%	169,399 $11.8 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $9.28 Million - $10.1 Million	146,233 Added 1352.26%	157,047 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $686,364 - $749,950	10,814 New	10,814 $10.8 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $262,751 - $294,350	-4,202 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $69,863 - $91,166	1,154 Added 37.86%	4,202 $263,000
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $39,916 - $44,195	-560 Reduced 15.52%	3,048 $235,000
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $23,356 - $27,244	360 Added 11.08%	3,608 $256,000
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $18,210 - $22,200	-250 Reduced 7.15%	3,248 $245,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $274,639 - $322,387	-3,860 Reduced 52.46%	3,498 $251,000
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $181,861 - $215,555	-2,522 Reduced 25.53%	7,358 $596,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,880	9,880 $699,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Gilead Sciences, Inc. Transaction History